Dr. Marina F.b. Caskey, MD

Dr. Caskey practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital.

Dr. Caskey's NPI, 1477501989, was assigned on May 5, 2006. Dr. Caskey graduated from Other in 1998. Dr. Caskey holds New York license 229382.

Dr. Caskey's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center, at 525 East 68th Street, New York, NY 10065 in New York County. The practice phone is (212) 746-5454.

Dr. Caskey's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Caskey to 2 more clinical labs and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Caskey practices, 4 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Caskey's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Caskey is board certified in infectious disease by the American Board of Internal Medicine. Dr. Caskey is licensed in New York.

Dmand AI lists joint or bone infection, UTI and yeast infection among the conditions Dr. Caskey treats.

CMS data shows 32 Medicare services from Dr. Caskey across 2 procedure codes in 2024, for 28 Medicare patients. Medicare paid $2,427 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 28 Medicare patients who saw Dr. Caskey in 2024. The largest group is 75 to 84, with 11 patients. 75% of them have arthritis, and 75% have high blood pressure. 43% are also on Medicaid. Their average risk score is 3.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Caskey's median patient age at 50, with 67% women.

In 2024, Dr. Caskey wrote 48 Medicare Part D claims. 94% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $12,606 in total drug cost. In 2022, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Caskey for performance year 2024, reported through an alternative payment model (APM). Dr. Caskey accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 94 papers to Dr. Caskey, published from 2011 to 2025. 2022 was the busiest year, with 20. The most frequent topics are Antibodies, Neutralizing, HIV-1 and HIV Infections. Dr. Caskey has published most often in bioRxiv. Dr. Caskey's most frequent co-authors are Michel C. Nussenzweig, MD, Thiago Oliveira, MD and Roy M. Gulick, MD, MPH.

Dmand AI links Dr. Caskey to 9 clinical trials, 8 of them phase 1 studies. 3 are still active or recruiting. Conditions studied include Acquired Immunodeficiency Syndrome, Slow Virus Diseases and Hepadnaviridae Infections. Rockefeller University sponsors the most, 7.

CMS Open Payments shows 37 general payments to Dr. Caskey from 4 drug and device companies from 2019 to 2025. Consulting fees make up the largest share, 90% of the total. Gilead Sciences, Inc. paid the most, $24,499.

Dr. Caskey graduated from Other in 1998.

Dr. Caskey is in network with 15 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.